Elekta establishes bond program

STOCKHOLM, March 9 – The Swedish Financial Supervisory Authority
(Finansinspektionen) has today approved Elekta’s (EKTA-B.ST) prospectus as part
of Elekta’s establishment of a Medium Term Note (MTN) Program, with a limit of
SEK 5 billion.
Elekta AB (publ) is the issuer of the MTN Program, which enables issuing of
bonds on the Swedish market.

“Effective financing is an important part in the continued implementation of our
strategic agenda and continued growth. The bond program gives us a broader
opportunity to diversify our funding,” says Håkan Bergström, CFO.

The prospectus is available on Elekta’s website www.elekta.com and will be
available at www.finansinspektionen.se.

Elekta has appointed Skandinaviska Enskilda Banken (SEB) as lead manager and
SEB, together with Danske Bank, as the issuing agent.

# # #

For further information, please contact:
Håkan Bergström, CFO, Elekta AB
Tel: +46 8 587 25 547, e-mail: hakan.bergstrom@elekta.com
Time zone: CET: Central European Time
Tobias Bülow, Director Financial Communication, Elekta AB
Tel: +46 722 215 017, e-mail: tobias.bulow@elekta.com
Time zone: CET: Central European Time
The information was published at 16:00 CET on March 9, 2015.
About Elekta
Elekta is a human care company pioneering significant innovations and clinical
solutions for treating cancer and brain disorders. The company develops
sophisticated, state-of-the-art tools and treatment planning systems for
radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing
software systems across the spectrum of cancer care. Stretching the boundaries
of science and technology, providing intelligent and resource-efficient
solutions that offer confidence to both health care providers and patients,
Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000
hospitals worldwide. Elekta employs around 3,800 employees globally. The
corporate headquarters is located in Stockholm, Sweden, and the company is
listed on NASDAQ Stockholm. Website: www.elekta.com.